Kidney regeneration approaches for translation

Heejo Yang1,2, Anthony Atala1, James J Yoo3

  • 1Wake Forest School of Medicine, Wake Forest Institute for Regenerative Medicine, Medical Center Boulevard, Winston-Salem, NC, 27157, USA.

World Journal of Urology
|November 8, 2019
PubMed

Insights

Chronic kidney disease (CKD) is a growing global health issue. Tissue engineering and regenerative medicine offer promising cell-based and cell-free therapies to address the shortage of donor kidneys for transplantation.

Area of Science:

  • Nephrology
  • Regenerative Medicine
  • Biotechnology

Background:

  • Rising incidence of chronic kidney diseases (CKD) progressing to end-stage renal disease (ESRD) presents a significant global health challenge.
  • Kidney transplantation is the only definitive treatment for ESRD, but a severe shortage of donor organs leads to high mortality rates among patients awaiting transplants.
  • Current treatments like dialysis can prolong survival but do not restore renal function.

Purpose of the Study:

  • To review current strategies and progress in tissue engineering and regenerative medicine for developing alternative therapeutic options for CKD.
  • To explore both cell-based and cell-free approaches aimed at addressing the challenges posed by CKD.
  • To highlight the potential of these innovative therapies in providing solutions for patients with kidney failure.

Main Methods:

  • Review of recent scientific literature and clinical studies on tissue engineering and regenerative medicine applied to kidney disease.
  • Analysis of cell-based strategies, including stem cell therapies and bioengineered kidney constructs.
  • Examination of cell-free approaches, such as therapeutic exosomes and growth factor delivery systems.

Main Results:

  • Tissue engineering and regenerative medicine are emerging as viable therapeutic avenues for kidney disease.
  • Both cell-based and cell-free strategies show potential in preclinical and early clinical studies.
  • Significant progress has been made in developing bio-artificial kidneys and regenerative therapies.

Conclusions:

  • Tissue engineering and regenerative medicine hold significant promise for overcoming the donor organ shortage in kidney transplantation.
  • Cell-based and cell-free approaches represent innovative solutions for treating chronic kidney diseases and end-stage renal disease.
  • Further research and clinical translation are crucial to realize the full therapeutic potential of these regenerative strategies.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
289
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
260
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
278